Share This

Related Topics News -

     
 < Previous page   Title only   |   Print 
     
歌禮製藥-B附屬新型法尼醇X受體激動劑研究表明耐受性良好

2023-11-06T  
醫藥股普遍下跌 歌禮、藥明生物、艾美、金斯瑞及三葉草挫5%-10%

2023-10-18T  
歌禮製藥-B治療痤瘡藥物III期臨床試驗快將啟動

2023-10-11T  
歌禮製藥-B慢性乙肝藥物取得積極期中數據

2023-09-29T  
歌禮製藥-B治療細胞瘤藥物臨床試驗完成120例患者入組

2023-09-26T  
《公司業績》歌禮製藥-B半年虧損收窄至1,655.9萬人幣 不派息

2023-08-22T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.